Novel functions of hendra virus G N-glycans and comparisons to Nipah virus

Journal of Virology

Volumn 89, Issue 14, 2015, Pages 7235-7247

  Bradel Tretheway, Birgit G ^a   Liu, Qian ^a   Stone, Jacquelyn A ^a   McInally, Samantha ^a   Aguilar, Hector C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G GLYCOPROTEIN; GLYCAN; N GLYCAN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN; ATTACHMENT PROTEIN G; MUTANT PROTEIN; POLYSACCHARIDE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL FUSION; CONTROLLED STUDY; HENDRA VIRUS; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NIPAH VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; VIRUS ENTRY; ANIMAL; CELL LINE; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

HENDRA VIRUS; NIPAH VIRUS; PARAMYXOVIRIDAE;

ANIMALS; CELL LINE; HENDRA VIRUS; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; NIPAH VIRUS; POLYSACCHARIDES; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84931038716     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00773-15     Document Type: Article

References (52)

1. Aguilar HC, Lee B. 2011. Emerging paramyxoviruses: molecular mechanisms and antiviral strategies. Expert Rev Mol Med 13:e6. http://dx.doi.org/10.1017/S1462399410001754.
2. Marsh GA, de Jong C, Barr JA, Tachedjian M, Smith C, Middleton D, Yu M, Todd S, Foord AJ, Haring V, Payne J, Robinson R, Broz I, Crameri G, Field HE, Wang LF. 2012. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog 8:e1002836. http://dx.doi.org/10.1371/journal.ppat.1002836.
3. Geisbert TW, Feldmann H, Broder CC. 2012. Animal challenge models of henipavirus infection and pathogenesis. Curr Top Microbiol Immunol 359:153-177. http://dx.doi.org/10.1007/82_2012_208.
4. Middleton D, Pallister J, Klein R, Feng YR, Haining J, Arkinstall R, Frazer L, Huang JA, Edwards N, Wareing M, Elhay M, Hashmi Z, Bingham J, Yamada M, Johnson D, White J, Foord A, Heine HG, Marsh GA, Broder CC, Wang LF. 2014. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health. Emerg Infect Dis 20:372-379. http://dx.doi.org/10.3201/eid2003.131159.
5. NSW Department of Primary Industries. 29 August 2014. reviewed. NSW Department of Primary Industries, agriculture: Hendra virus, current situation July 2014. http://www.dpi.nsw.gov.au/agriculture/livestock/horses/health/general/hendra-virus.
6. Hazelton B, Ba Alawi F, Kok J, Dwyer DE. 2013. Hendra virus: a one health tale of flying foxes, horses and humans. Future Microbiol 8:461-474. http://dx.doi.org/10.2217/fmb.13.19.
7. Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang LF. 2013. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res 100:8-13. http://dx.doi.org/10.1016/j.antiviral.2013.06.012.
8. Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC. 2014. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Sci Transl Med 6:242ra82. http://dx.doi.org/10.1126/scitranslmed.3008929.
9. Bossart KN, Fusco DL, Broder CC. 2013. Paramyxovirus entry. Adv Exp Med Biol 790:95-127. http://dx.doi.org/10.1007/978-1-4614-7651-1_6.
10. Lamb RA, Paterson RG, Jardetzky TS. 2006. Paramyxovirus membrane fusion: lessons from the F andHNatomic structures. Virology 344:30-37. http://dx.doi.org/10.1016/j.virol.2005.09.007.
11. Liu Q, Stone JA, Bradel-Tretheway B, Dabundo J, Benavides Montano JA, Santos-Montanez J, Biering SB, Nicola AV, Iorio RM, Lu X, Aguilar HC. 2013. Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced Nipah virus fusion and cell entry. PLoS Pathog 9:e1003770. http://dx.doi.org/10.1371/journal.ppat.1003770.
12. Bishop KA, Hickey AC, Khetawat D, Patch JR, Bossart KN, Zhu Z, Wang LF, Dimitrov DS, Broder CC. 2008. Residues in the stalk domain of the Hendra virus G glycoprotein modulate conformational changes associated with receptor binding. J Virol 82:11398-11409. http://dx.doi.org/10.1128/JVI.02654-07.
13. Maar D, Harmon B, Chu D, Schulz B, Aguilar HC, Lee B, Negrete OA. 2012. Cysteines in the stalk of the Nipah virusGglycoprotein are located in a distinct subdomain critical for fusion activation. J Virol 86:6632-6642. http://dx.doi.org/10.1128/JVI.00076-12.
14. Biering SB, Huang A, Vu AT, Robinson LR, Bradel-Tretheway B, Choi E, Lee B, Aguilar HC. 2012. N-glycans on the Nipah virus attachment glycoprotein modulate fusion and viral entry as they protect against antibody neutralization. J Virol 86:11991-12002. http://dx.doi.org/10.1128/JVI.01304-12.
15. Guillaume V, Aslan H, Ainouze M, Guerbois M, Wild TF, Buckland R, Langedijk JP. 2006. Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model. J Virol 80:7546-7554. http://dx.doi.org/10.1128/JVI.00190-06.
16. Negrete OA, Chu D, Aguilar HC, Lee B. 2007. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage. J Virol 81:10804-10814. http://dx.doi.org/10.1128/JVI.00999-07.
17. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B. 2005. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436:401-405. http://dx.doi.org/10.1038/nature03838.
18. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Muhlberger E, Su SV, Bertolotti-Ciarlet A, Flick R, Lee B. 2006. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2:e7. http://dx.doi.org/10.1371/journal.ppat.0020007.
19. Levroney EL, Aguilar HC, Fulcher JA, Kohatsu L, Pace KE, Pang M, Gurney KB, Baum LG, Lee B. 2005. Novel innate immune functions for galectin-1: galectin-1 inhibits cell fusion by Nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines. J Immunol 175:413-420. http://dx.doi.org/10.4049/jimmunol.175.1.413.
20. Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, Negrete OA, Bertolotti-Ciarlet A, Choi DY, McHardy I, Fulcher JA, Su SV, Wolf MC, Kohatsu L, Baum LG, Lee B. 2006. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol 80:4878-4889. http://dx.doi.org/10.1128/JVI.80.10.4878-4889.2006.
21. Aguilar HC, Ataman ZA, Aspericueta V, Fang AQ, Stroud M, Negrete OA, Kammerer RA, Lee B. 2009. A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F). J Biol Chem 284:1628-1635. http://dx.doi.org/10.1074/jbc.M807469200.
22. Aguilar HC, Matreyek KA, Choi DY, Filone CM, Young S, Lee B. 2007. Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling. J Virol 81:4520-4532. http://dx.doi.org/10.1128/JVI.02205-06.
23. Whitman SD, Dutch RE. 2007. Surface density of the Hendra G protein modulates Hendra F protein-promoted membrane fusion: role for Hendra G protein trafficking and degradation. Virology 363:419-429. http://dx.doi.org/10.1016/j.virol.2007.01.029.
24. Colgrave ML, Snelling HJ, Shiell BJ, Feng YR, Chan YP, Bossart KN, Xu K, Nikolov DB, Broder CC, Michalski WP. 2012. Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus. Glycobiology 22:572-584. http://dx.doi.org/10.1093/glycob/cwr180.
25. Xu K, Chan YP, Rajashankar KR, Khetawat D, Yan L, Kolev MV, Broder CC, Nikolov DB. 2012. New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2. PLoS One 7:e48742. http://dx.doi.org/10.1371/journal.pone.0048742.
26. White JM, Delos SE, Brecher M, Schornberg K. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 43:189-219. http://dx.doi.org/10.1080/10409230802058320.
27. Liu Q, Bradel-Tretheway B, Monreal AI, Saludes JP, Lu X, Nicola AV, Aguilar HC. 2015. Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering. J Virol 89:1838-1850. http://dx.doi.org/10.1128/JVI.02277-14.
28. Zhu Q, Biering SB, Mirza AM, Grasseschi BA, Mahon PJ, Lee B, Aguilar HC, Iorio RM. 2013. Individual N-glycans added at intervals along the stalk of the Nipah virus G protein prevent fusion but do not block the interaction with the homologous F protein. J Virol 87:3119-3129. http://dx.doi.org/10.1128/JVI.03084-12.
29. Mirza AM, Aguilar HC, Zhu Q, Mahon PJ, Rota PA, Lee B, Iorio RM. 2011. Triggering of the Newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptors. J Biol Chem 286:17851-17860. http://dx.doi.org/10.1074/jbc.M111.233965.
30. Kropff B, Burkhardt C, Schott J, Nentwich J, Fisch T, Britt W, Mach M. 2012. Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies. PLoS Pathog 8:e1002999. http://dx.doi.org/10.1371/journal.ppat.1002999.
31. Lennemann NJ, Rhein BA, Ndungo E, Chandran K, Qiu X, Maury W. 2014. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. mBio 5(1):e00862-13. http://dx.doi.org/10.1128/mBio.00862-13.
32. Julithe R, Abou Jaoude G, Sureau C. 2014. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies. J Virol 88:9049-9059. http://dx.doi.org/10.1128/JVI.01161-14.
33. de Haan CA, de Wit M, Kuo L, Montalto-Morrison C, Haagmans BL, Weiss SR, Masters PS, Rottier PJ. 2003. The glycosylation status of the murine hepatitis coronavirusMprotein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology 312:395-406. http://dx.doi.org/10.1016/S0042-6822(03)00235-6.
34. Laude H, Gelfi J, Lavenant L, Charley B. 1992. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J Virol 66:743-749.
35. Vigerust DJ, Shepherd VL. 2007. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15:211-218. http://dx.doi.org/10.1016/j.tim.2007.03.003.
36. McGinnes L, Sergel T, Reitter J, Morrison T. 2001. Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity. Virology 283:332-342. http://dx.doi.org/10.1006/viro.2001.0899.
37. Sawatsky B, von Messling V. 2010. Canine distemper viruses expressing a hemagglutinin without N-glycans lose virulence but retain immunosuppression. J Virol 84:2753-2761. http://dx.doi.org/10.1128/JVI.01813-09.
38. Bowden TA, Crispin M, Harvey DJ, Aricescu AR, Grimes JM, Jones EY, Stuart DI. 2008. Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design. J Virol 82:11628-11636. http://dx.doi.org/10.1128/JVI.01344-08.
39. Bowden TA, Crispin M, Harvey DJ, Jones EY, Stuart DI. 2010. Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol 84:6208-6217. http://dx.doi.org/10.1128/JVI.00317-10.
40. Xu K, Rajashankar KR, Chan YP, Himanen JP, Broder CC, Nikolov DB. 2008. Host cell recognition by the henipaviruses: crystal structures of the NipahGattachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci USA 105:9953-9958. http://dx.doi.org/10.1073/pnas.0804797105.
41. Xu K, Rockx B, Xie Y, DeBuysscher BL, Fusco DL, Zhu Z, Chan YP, Xu Y, Luu T, Cer RZ, Feldmann H, Mokashi V, Dimitrov DS, Bishop-Lilly KA, Broder CC, Nikolov DB. 2013. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. PLoS Pathog 9:e1003684. http://dx.doi.org/10.1371/journal.ppat.1003684.
42. Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, Smith JK, Zhang LH, Wang YE, Vigant F, Gao JL, Wu P, Lee B, Freiberg AN. 2015. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection. J Virol 89:1242-1253. http://dx.doi.org/10.1128/JVI.02583-14.
43. Popa A, Carter JR, Smith SE, Hellman L, Fried MG, Dutch RE. 2012. Residues in the Hendra virus fusion protein transmembrane domain are critical for endocytic recycling. J Virol 86:3014-3026. http://dx.doi.org/10.1128/JVI.05826-11.
44. Bager R, Johansen JS, Jensen JK, Stensballe A, Jendroszek A, Buxbom L, Sorensen HP, Andreasen PA. 2013. Protein conformational change delayed by steric hindrance from an N-linked glycan. J Mol Biol 425:2867-2877. http://dx.doi.org/10.1016/j.jmb.2013.05.007.
45. Jardetzky TS, Lamb RA. 2014. Activation of paramyxovirus membrane fusion and virus entry. Curr Opin Virol 5:24-33. http://dx.doi.org/10.1016/j.coviro.2014.01.005.
46. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, Goldsmith CS, Gubler DJ, Roehrig JT, Eaton B, Gould AR, Olson J, Field H, Daniels P, Ling AE, Peters CJ, Anderson LJ, Mahy BW. 2000. Nipah virus: a recently emergent deadly paramyxovirus. Science 288:1432-1435. http://dx.doi.org/10.1126/science.288.5470.1432.
47. Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, Rota PA. 2000. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology 271:334-349. http://dx.doi.org/10.1006/viro.2000.0340.
48. White JR, Boyd V, Crameri GS, Duch CJ, van Laar RK, Wang LF, Eaton BT. 2005. Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus. J Gen Virol 86:2839-2848. http://dx.doi.org/10.1099/vir.0.81218-0.
49. Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS. 2008. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis 197:846-853. http://dx.doi.org/10.1086/528801.
50. Willett BJ, McMonagle EL, Logan N, Samman A, Hosie MJ. 2008. A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction. Retrovirology 5:77. http://dx.doi.org/10.1186/1742-4690-5-77.
51. Ma BJ, Alam SM, Go EP, Lu X, Desaire H, Tomaras GD, Bowman C, Sutherland LL, Scearce RM, Santra S, Letvin NL, Kepler TB, Liao HX, Haynes BF. 2011. Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathog 7:e1002200. http://dx.doi.org/10.1371/journal.ppat.1002200.
52. Bachmann MF, Zinkernagel RM. 1997. Neutralizing antiviral B cell responses. Annu Rev Immunol 15:235-270. http://dx.doi.org/10.1146/annurev.immunol.15.1.235.